about
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating man...
Read More
4.64
0.04
(0.87%)
57,645.0
XNAS Volume
XNAS 06 Aug, 2026 12:34 PM (EDT)
Board Meeting
The next board meeting for Polypid Ltd is on 13 Aug 2026 for the purpose of PolyPid Ltd Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Polypid Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..